Clinical trial
Study of Metastatic Ocular Melanoma
NCT00168870 · Charite University, Berlin, Germany, Other · Unknown status
Key facts
| NCT number | NCT00168870 |
|---|---|
| Title | Study of Metastatic Ocular Melanoma |
| Official title | Randomized Phase II Study to Compare a Combination Therapy With Gemcitabine and Treosulfan Versus a Monotherapy as First-Line Chemotherapy for Patients With Metastatic Ocular Melanoma |
| Lead sponsor | Charite University, Berlin, Germany, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ocular Melanoma |
| Intervention type | Drug |
| Interventions | Gemcitabine, Treosulfan |
| Enrollment | 48 |
| Start date | Feb 1, 2003 |
| First posted | Sep 15, 2005 |
| Last update posted | Aug 31, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: